A perspective on the trade-offs between safety & efficacy in 1st line RCC

David I. Quinn, MD,the trade-offs between safety and efficacy in 1st line renal cell carcinoma (RCC) treatment options at the 2018 Annual Meeting. Author: obr Added: 07/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts